ETV1 and prostate carcinoma: Tomlins et al. [11] identified recurrent genomic rearrangements in prostate cancer resulting in the fusion of the 5′ untranslated end of TMPRSS2 (a prostate-specific, androgen-responsive, transmembrane serine protease gene) to ETS family members (ERG, ETV1, ETV4).